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Abstract
We present a case in which p16 immunocytochemistry helped establish the diagnosis of
Trichomonas  in urine from a male patient. Based on this finding, we recommend p16
immunocytochemistry as a diagnostic tool for unexpected patients or specimen types in which
potential trichomonads are identified following routine cytologic evaluation.
Article
We received 50 ml of voided urine from a 84-year-old dia-
betic male who presented with hematuria. Routine urine
cultures yielded no growth after 24 hours. A Papanico-
laou-stained ThinPrep™ slide was prepared which
revealed benign urothelial cells, neutrophils including
"cannonballs" (i.e. neutrophils aggregated around epithe-
lial cells), red blood cells and numerous Trichomonas
organisms (Figure 1). The diagnosis of Trichomonas was
based upon the presence of a discernible nucleus and
cytoplasmic granules that were identified in several of the
trichomonads. A visible nucleus and well-defined cyto-
plasmic granules at 40x magnification are specified as
important morphological features required for a confi-
dent diagnosis of Trichomonas in liquid-based Pap tests
[1]. Although we did not identify flagella in the tri-
chomonads in our case, the finding of flagella, while help-
ful, is not always required to make a diagnosis of
Trichomonas [1]. In fact, the morphologic identification of
Trichomonas on liquid-based Pap tests has been shown to
be highly accurate [2]. Nevertheless, exfoliated cells
including microorganisms in urine are often degenerated,
which makes the identification of Trichomonas in these
specimens by morphology alone difficult. Therefore, con-
firmatory testing may be needed. However, traditional
methods to detect Trichomonas including culture and wet-
mount microscopy, as well as molecular studies, may not
always be readily available, particularly on fixed samples
received in liquid-based vials for cytologic evaluation.
In order to differentiate parasites from degenerated
urothelial cells in our case we prepared additional Thin-
Prep™ slides from the residual specimen to perform
immunocytochemistry for cytokeratin (using a cocktail of
high- and low-molecular weight keratins) and p16 (using
primary purified mouse anti-human p16 antibody, clone
G175-405, supplied by BD Biosciences Pharmingen, San
Diego, CA, USA). We included p16 based upon recent
published data by our group indicating that Trichomonas
vaginalis  organisms in cervicovaginal specimens are
immunoreactive for p16 [3]. In all ten of these cervicovag-
inal specimens T. vaginalis were p16 positive and demon-
strated strong cytoplasmic staining. Immunocytochemical
staining for p16, a proven biomarker for high grade dys-
plasia associated with Human Papillomavirus (HPV)
infection, has been previously applied successfully to cer-
vicovaginal cytology specimens [4]. However, p16 immu-
noreactivity is not specific for HPV-infected epithelium, as
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immunoreactivity has previously been documented with
inflammatory cells, multinucleated giant cells, bacteria
and mucus in cervicovaginal specimens [4-6]. It is unclear
if p16 staining of Trichomonas organisms reflects specific
immunoreactivity (to unknown epitopes) or may be non-
specific. In our case, urothelial and squamous cells were
strongly immunoreactive for cytokeratin (Figure 2) but
were negative for p16, whereas trichomonads demon-
Group of Trichomonas organisms present in urine (Thin- Prep™, Papanicolaou stain) Figure 1
Group of Trichomonas organisms present in urine (Thin-
Prep™, Papanicolaou stain).
Cytokeratin immunocytochemistry Figure 2
Cytokeratin immunocytochemistry. A single urothelial cell 
demonstrates strong cytokeratin immunoreactivity whereas 
surrounding trichomonads are negative. Degenerated inflam-
matory cells are also present in this field.
p16 immunocytochemistry Figure 3
p16 immunocytochemistry. A group of trichomonads dem-
onstrate strong p16 immunoreactivity whereas an adjacent 
degenerated urothelial cell and squamous cell are negative.
A single trichomonad, adjacent to an unstained exfoliated  squamous epithelial cell, is shown to be p16 immunoreactive Figure 4
A single trichomonad, adjacent to an unstained exfoliated 
squamous epithelial cell, is shown to be p16 immunoreactive.Publish with BioMed Central    and   every 
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strated strong p16 immunoreactivity (Figure 3 and Figure
4) and failed to react with cytokeratin. Appropriate con-
trols were included in this study (data not shown). Fol-
lowing the diagnosis of Trichomonas, our patient was
treated with a course of metronidazole.
Trichomonas infection in male patients may be asympto-
matic or associated with non-gonococcal urethritis, pros-
tatitis, and urethral strictures. Protozoa in men may be
harbored in the uncircumcised prepuce, urethra, seminal
vesicles, prostate gland or bladder. As shown in the
present case, it is often difficult to establish the diagnosis
of Trichomonas in men, particularly when the diagnosis is
based solely on the cytological evaluation of poorly pre-
served organisms in a urine specimen. The diagnosis may
be especially problematic when the patient denies sexual
contact, or when a sexually transmitted disease in a partic-
ular patient, such as an infant [7] or the elderly, seems
implausible. Adding to the problem is the fact that when
in urine, trichomonads usually assume variable shapes
[8]. Parasite variation in size and shape may be further
exaggerated in air-dried urine smears [9]. In male patients,
the organisms also tend to be somewhat smaller than
their counterpart in female patients [10]. In addition to
the present patient, our laboratory has diagnosed Tri-
chomonas  in Papanicolaou-stained urine specimens in
eight men of mean age 59 years (range 47–82 years), over
a 15 year period. This finding is in keeping with published
data suggesting that higher organism loads occur in older
men [11]. We do not know if any of these individuals also
had diabetes.
In conclusion, as illustrated in the case presented, we rec-
ommend the use of p16 immunocytochemistry to help
establish the diagnosis of Trichomonas  in unexpected
patients or specimen types in which potential trichomon-
ads are identified following routine cytologic evaluation.
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